First FcRn blocker to demonstrate sustained disease control over 24 weeks in antibody positive adolescents aged 12 – 17 years, broadening the population in which nipocalimab has been studied...

Nanoscope Therapeutics, Inc., a BLA filing-stage biotechnology company developing gene therapies for retinal degenerative diseases, today announced that Nanoscope will present at the AAO 2024...

Moss Adams, one of the largest accounting, consulting and wealth management firms in the nation, announced details for its upcoming 2024 Executive Health Care Conference, taking place November...

Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, announced that Tony DiTonno, CEO and Executive Chairman, will provide a status update on the...

Estonia, a recognised global leader in digital transformation, is preparing to cement its position as a hub of technological innovation at GITEX Global 2024, to be held in Dubai from 14 to 18...